Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02XHM
|
|||
Former ID |
DNC007331
|
|||
Drug Name |
3-[10-(benzylmethylamino)decyloxy]xanthen-9-one
|
|||
Synonyms |
CHEMBL390598; 3-[10-(benzylmethylamino)decyloxy]xanthen-9-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C31H37NO3
|
|||
Canonical SMILES |
CN(CCCCCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4
|
|||
InChI |
1S/C31H37NO3/c1-32(24-25-15-9-8-10-16-25)21-13-6-4-2-3-5-7-14-22-34-26-19-20-28-30(23-26)35-29-18-12-11-17-27(29)31(28)33/h8-12,15-20,23H,2-7,13-14,21-22,24H2,1H3
|
|||
InChIKey |
YOTLTNQICYMZSI-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
Nicotinic acetylcholine receptor signaling pathway | ||||
WikiPathways | Irinotecan Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones. Bioorg Med Chem. 2007 Jan 1;15(1):575-85. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.